IEFM
LAB icon

IQ EQ Fund Management’s Standard BioTools LAB Stock Holding History

IQ EQ Fund Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-108,416
Closed -$139K – 307
2025
Q4 		$139K Buy
108,416
+35,069
+48% +$47.1K 0.01% 287
2025
Q3 		$95.4K Buy
73,347
+28,050
+62% +$36.7K 0.01% 315
2025
Q2 		$54.4K Buy
45,297
+18,178
+67% +$20.1K ﹤0.01% 308
2025
Q1 		$29.3K Buy
27,119
+14,541
+116% +$20.4K ﹤0.01% 304
2024
Q4 		$22K Sell
12,578
-7,148
-36% -$13.3K ﹤0.01% 298
2024
Q3 		$38.1K Sell
19,726
-2,246
-10% -$4.4K ﹤0.01% 322
2024
Q2 		$38.9K Buy
+21,972
New +$53.7K ﹤0.01% 310

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

IQ EQ Fund Management's LAB Position: Q1 2026 in Review

IQ EQ Fund Management sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 108,416 shares — an estimated $139K sold.

IQ EQ Fund Management first reported a position in LAB in Q2 2024 and held it in 7 quarters. The position peaked at $139K in Q4 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • IQ EQ Fund Management reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
  • IQ EQ Fund Management sold 108,416 Standard BioTools shares in Q1 2026, an estimated $139K.
  • IQ EQ Fund Management first reported a position in Standard BioTools in Q2 2024 and held it in 7 quarters.
  • IQ EQ Fund Management's Standard BioTools position peaked at $139K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.